The short version
27 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Carbamazepine
Carbamazepine · CARBAMAZEPINE 200 mg/1 · Tablet · Oral · Unichem Pharmaceuticals (USA), Inc.
NDC 29300-0382-05 · 500 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 51672-4005-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.1951per unit
middle half $0.1642–$0.3060 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.1951
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for carbamazepine (oral solid) in the next 90 days
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA213284
- TE code
- AB
- Approval date
- Aug 22, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Carbamazepine (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Preferred Pharmaceuticals Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bionpharma Inc., | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| direct rx | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novartis Pharmaceuticals Corporation | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Manufacturing Services LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Umedica Laboratories USA Inc. | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Umedica Laboratories USA Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 1, 2026 |
| Teva Pharmaceuticals USA, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Jul 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Carbamazepine — NDC 29300-0382-05," retrieved September 3, 2026, https://drugdashboards.com/drug/29300038205.
Free to cite with attribution — see how the data is put together.